Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing
Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4